FDA Seeks Comment On Guidance For Clinical Trial Sponsors
The U.S. Food and Drug Administration is set to publish draft guidance on Tuesday that aims to help clinical trial sponsors determine when they need to bring in a group of data...To view the full article, register now.
Already a subscriber? Click here to view full article